
-
Iran vows retaliation for US strikes as Israel keeps up attacks
-
Russian drone and missile barrage on Kyiv kills seven
-
Oil rises, dollar firms after US strikes in Iran
-
'Noble to attend': Budapest prepares for 'banned' Pride march
-
Art market banking on new generation of collectors
-
Turning 80, UN faces fresh storm of doubts
-
'A great start': NBA crown just the beginning for Shai
-
Man City hit six to reach Club World Cup last 16, Real Madrid win with 10 men
-
Iran vows retaliation after US strikes on nuclear sites
-
'Massive' Russian attack on Kyiv kills at least five: Ukraine
-
Groundbreaking Vera Rubin Observatory reveals first images
-
Thunder beat Pacers in game seven, cap stunning season with NBA crown
-
Pacers 'hearts dropped' after Haliburton injury: Carlisle
-
Ukraine says 'massive' Russian attack on Kyiv
-
Thunder's Gilgeous-Alexander named NBA Finals MVP
-
Thunder beat injury-hit Pacers in game seven to win NBA title
-
Oil prices spike after US strikes on Iran
-
Man City demolish Al Ain to reach Club World Cup last 16
-
Thunder beat Pacers to clinch first NBA Finals crown
-
Bone collectors: searching for WWII remains in Okinawa
-
Madrid coach Alonso says Rudiger complained of racist insult in Club World Cup win
-
Girls shouldn't shout?: Women break the mould at French metal festival
-
Indian activists seek to save child brides
-
Jonathan Anderson set for Dior debut at Paris Fashion Week
-
Ukraine says 'massive' Russian drone attack on Kyiv
-
Oasis: from clash to cash
-
Toxic threat from 'forever chemicals' sparks resistance in Georgia towns
-
All Blacks name five debutants in squad for France Tests
-
Pacers' Haliburton hurt early in game seven against Thunder
-
Suicide attack on Damascus church kills at least 22
-
French police probe fake Disneyland 'marriage' with nine-year-old
-
BioNxt Launches Feasibility Study for Semaglutide Oral Thin Film as Alternative to Injection/Tablets
-
Xebra Announces Delay in Filing Financial Statements
-
Vision Marine Technologies Acquires Nautical Ventures Group, Boating Industry 2024 Top 100 Dealer of the Year
-
Ohtani bags strikeouts, home run as Dodgers rout Nats
-
Hall of Fame trainer Lukas ill, won't return to racing: Churchill Downs
-
US Ryder Cup captain Bradley edges Fleetwood to win PGA Travelers
-
Alonso says Rudiger complained of racist insult
-
Minjee Lee wins Women's PGA Championship for third major title
-
US bases in the Middle East
-
More than 20 killed in suicide attack on Damascus church
-
Ten-man Real Madrid show class in Pachuca win
-
Blood, destruction at Damascus church after suicide attack
-
Tesla launches long-discussed robotaxi service
-
Palou wins at Road America to boost IndyCar season lead
-
Bumrah says 'fate' behind Brook's exit for 99 against India
-
Gout Gout says 100m 'too short' for him
-
Democrats assail 'erratic' Trump over Iran strikes
-
Iran threatens US bases in response to strikes on nuclear sites
-
NBA Suns trade star forward Kevin Durant to Rockets

Moderna to Present at Upcoming Conferences in June 2025
CAMBRIDGE, MA / ACCESS Newswire / May 27, 2025 / Moderna, Inc. (Nasdaq:MRNA), today announced its participation in the following upcoming investor conferences:
Jefferies Global Health Care Conference, on Thursday, June 5th at 10:30am ET
Goldman Sachs 46th Annual Global Healthcare Conference, on Wednesday, June 11th at 8:40am ET
A live webcast of each of these presentations will be available under "Events and Presentations" in the Investors section of the Moderna website.
A replay of each webcast will be archived on Moderna's website for at least 30 days following the presentation.
About Moderna
Moderna is a leader in the creation of the field of mRNA medicine. Through the advancement of mRNA technology, Moderna is reimagining how medicines are made and transforming how we treat and prevent disease for everyone. By working at the intersection of science, technology and health for more than a decade, the company has developed medicines at unprecedented speed and efficiency, including one of the earliest and most effective COVID-19 vaccines.
Moderna's mRNA platform has enabled the development of therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases and autoimmune diseases. With a unique culture and a global team driven by the Moderna values and mindsets to responsibly change the future of human health, Moderna strives to deliver the greatest possible impact to people through mRNA medicines. For more information about Moderna, please visit modernatx.com and connect with us on X (formerly Twitter), Facebook, Instagram, YouTube and LinkedIn.
Investors:
Lavina Talukdar
Senior Vice President & Head of Investor Relations
617-209-5834
[email protected]
SOURCE: Moderna, Inc.
View the original press release on ACCESS Newswire
P.Stevenson--AMWN